BU-NOT-SET

CONTACT US
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Global expansion in the CDMO field
  • Industry trends
Eyes
Insight
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
White paper
  • Analytical chemistry
  • Drug product
Developing a robust dissolution method for low-dose formulations
Report
  • Sustainability
Sustainability report 2022
Insight
  • Drug product
  • Industry trends
Navigating the changing oral solid dose landscape
Insight
  • Drug product
  • Manufacturing
The opportunities and obstacles of filling and packaging pre-filled syringes
Insight
  • Drug product
  • Industry trends
Tips for facilitating a successful tech transfer between sponsor and CDMO
Insight
  • Drug product
  • Industry trends
Alternative drug delivery formulation & device expertise
Insight
  • Industry trends
The 3 key trends shaping the CDMO industry in 2023 and beyond
Insight
  • Drug product
  • Industry trends
Three challenges pharma companies can overcome when choosing the right OSD partner
Insight
  • Sustainability
Sustainable pharmaceutical supply chains with the Science Based Targets initiative